Search research articles
Contact Us
Filters
Showing results (71-80 of 186) with videos related to
Page
of 19
Sort By:
Gynecologic Oncology
|
October 26, 2013
Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network
Denis Maillet, Thibaut Goulvent, Ruth Rimokh, et al.
International Journal of Cancer
|
April 5, 2013
Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor
Paul Vilquin, Marie Villedieu, Evelyne Grisard, et al.
Endocrine-Related Cancer
|
May 18, 2022
MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cells
Razan Abou Ziki, Romain Teinturier, Yakun Luo, et al.
Cancer Research
|
January 14, 2018
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
Adrien Nougarede, Nikolay Popgeorgiev, Loay Kassem, et al.
Breast Cancer Research and Treatment
|
September 25, 2021
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
Romain Teinturier, Razan Abou Ziki, Loay Kassem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma
Hiroyuki Fujiwara, Harushige Yokota, Bradley Monk, et al.
Molecular Oncology
|
June 29, 2014
A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers
Nhan T Nguyen, Julie A Vendrell, Coralie Poulard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 29, 2025
Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy
Chloé Barbier de Reulle, Marine Rebotier, Nicolas Chopin, et al.
Histopathology
|
June 3, 2015
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study
Thibault Goulvent, Isabelle Ray-Coquard, Stéphane Borel, et al.
Bulletin Du Cancer
|
September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectives
Laetitia Collet, Andrea María González López, Clémence Romeo, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 186) with videos related to
Sort By:
Page
of 19
Gynecologic Oncology
|
October 26, 2013
Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network
Denis Maillet, Thibaut Goulvent, Ruth Rimokh, et al.
International Journal of Cancer
|
April 5, 2013
Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor
Paul Vilquin, Marie Villedieu, Evelyne Grisard, et al.
Endocrine-Related Cancer
|
May 18, 2022
MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cells
Razan Abou Ziki, Romain Teinturier, Yakun Luo, et al.
Cancer Research
|
January 14, 2018
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10
Adrien Nougarede, Nikolay Popgeorgiev, Loay Kassem, et al.
Breast Cancer Research and Treatment
|
September 25, 2021
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
Romain Teinturier, Razan Abou Ziki, Loay Kassem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma
Hiroyuki Fujiwara, Harushige Yokota, Bradley Monk, et al.
Molecular Oncology
|
June 29, 2014
A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers
Nhan T Nguyen, Julie A Vendrell, Coralie Poulard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 29, 2025
Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy
Chloé Barbier de Reulle, Marine Rebotier, Nicolas Chopin, et al.
Histopathology
|
June 3, 2015
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study
Thibault Goulvent, Isabelle Ray-Coquard, Stéphane Borel, et al.
Bulletin Du Cancer
|
September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectives
Laetitia Collet, Andrea María González López, Clémence Romeo, et al.
Page
of 19